Physician profile
Kyle J Michaelis
NPI 1861486425
$20,702.41
in general payments reported to CMS, 2019-2025
33 companies · $2,690 in 2025
The $2,690 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,529 · 2020: $1,738 · 2021: $2,512 · 2022: $5,385 · 2023: $2,495 · 2024: $2,353 · 2025: $2,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,539.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $13,731.15 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Impulse Dynamics (USA) INC. | $1,222.38 | 2023-2025 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $1,064.33 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $808.32 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $680.94 | 2019-2024 | Xarelto |
| Amgen INC. | $605.51 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $359.86 | 2019-2023 | |
| Abbott Laboratories | $287.47 | 2022-2024 | Merlin@Home, Cardiomems |
| Kestra Medical Technology Services, INC. | $266.03 | 2022-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $223.19 | 2021-2024 | Verquvo |
| Pfizer INC. | $220.30 | 2019-2024 | |
| Atricure, INC. | $188.13 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $174.86 | 2021-2025 | |
| Edwards Lifesciences Corporation | $120.20 | 2019 | |
| Heartflow, INC. | $105.94 | 2021-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $77.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $76.81 | 2021-2024 | Camzyos |
| Arbor Pharmaceuticals, INC. | $68.10 | 2019-2022 | |
| Biosense Webster, INC. | $66.08 | 2025 | Carto 3 |
| Philips North America LLC | $43.74 | 2020 | |
| Bardy Diagnostics, INC. | $42.30 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $37.69 | 2024 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $35.94 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $28.90 | 2021-2023 | Farxiga |
| Scpharmaceuticals INC. | $24.26 | 2023 | |
| B. Braun Interventional Systems INC. | $19.73 | 2025 | Cp Stent |
| Medtronic Vascular, INC. | $18.22 | 2020 | |
| Azurity Pharmaceuticals, INC. | $16.45 | 2024 | Edarbi |
| Lundbeck LLC | $15.94 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $14.10 | 2023 | Arcalyst |
| Gilead Sciences, INC. | $13.63 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Michaelis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.